SEGMENT REPORTING (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Results of Operations for Reportable Segment

The following table reflects results of operations of the Company’s reportable segment (in thousands):

	Year Ended December 31,
	2025		2024		2023
Infusion services net revenue	$	5,555,778	$	4,911,591	$	4,222,656
Other revenue (1)	93,741		86,611		79,668
Total Option Care Health revenue	5,649,519		4,998,202		4,302,324
(Expense) Income:
Cost of net revenues - drugs	(3,984,955)		(3,446,735)		(2,812,531)
Salaries, benefits, and other employee expense	(848,996)		(787,922)		(760,499)
Other segment items (2)	(410,124)		(380,803)		(355,498)
Depreciation and amortization expense	(67,538)		(60,909)		(59,201)
Interest expense, net	(54,558)		(49,029)		(51,248)
Equity in earnings of joint ventures	7,409		5,964		5,530
Other, net	(7,857)		4,831		89,865
Income tax expense	(75,315)		(71,776)		(91,652)
Net Income	$	207,585	$	211,823	$	267,090

(1) Represents business activities related to other miscellaneous revenue streams.

(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.